<code id='9472D5B263'></code><style id='9472D5B263'></style>
    • <acronym id='9472D5B263'></acronym>
      <center id='9472D5B263'><center id='9472D5B263'><tfoot id='9472D5B263'></tfoot></center><abbr id='9472D5B263'><dir id='9472D5B263'><tfoot id='9472D5B263'></tfoot><noframes id='9472D5B263'>

    • <optgroup id='9472D5B263'><strike id='9472D5B263'><sup id='9472D5B263'></sup></strike><code id='9472D5B263'></code></optgroup>
        1. <b id='9472D5B263'><label id='9472D5B263'><select id='9472D5B263'><dt id='9472D5B263'><span id='9472D5B263'></span></dt></select></label></b><u id='9472D5B263'></u>
          <i id='9472D5B263'><strike id='9472D5B263'><tt id='9472D5B263'><pre id='9472D5B263'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:3942
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Eyeing GLP
          Eyeing GLP

          AdobeDigitaltherapeuticscompanyClickTherapeuticsannouncedWednesdayitwillacquiretheassetsofBetterTher

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo